Life AI Net
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
تسجيل الدخول
العربية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
تسجيل الدخول
الرئيسية
الأرشيف
الحاسبات
الدليل
More
مباشر
BioPharma Dive
Cytospire hauls in $83M for a new type of T cell engager
Samsung Biologics
Samsung Biologics Labor Talks Break Down, Gap Remains - thelec.net
Siemens Healthineers
CDC HoSt-TT certification for Siemens Healthineers total testosterone test expands patient access to gold standard equivalent results - News-Medical
Samsung Biologics
Samsung Biologics union continues first general strike, demands higher wages and performance-based pay - Korea JoongAng Daily
FierceBiotech
Private Swiss biotechs hit record funding amid slowdown in public financing
Samsung Biologics
Samsung Biologics' strike enters 5th day - Yonhap News Agency
eLife
Are kinocilia motile?
eLife
Human adherent cortical organoids in a multi-well format
Endpoints News
Vertex drops mRNA cystic fibrosis program over 'tolerability' issues
Bio-Rad
Bio-Rad Navigates Academic Headwinds and Geopolitical Shifts in Q1 2026 Financial Results - Lab Manager
FierceBiotech
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
BioPharma Dive
Cytospire hauls in $83M for a new type of T cell engager
Samsung Biologics
Samsung Biologics Labor Talks Break Down, Gap Remains - thelec.net
Siemens Healthineers
CDC HoSt-TT certification for Siemens Healthineers total testosterone test expands patient access to gold standard equivalent results - News-Medical
Samsung Biologics
Samsung Biologics union continues first general strike, demands higher wages and performance-based pay - Korea JoongAng Daily
FierceBiotech
Private Swiss biotechs hit record funding amid slowdown in public financing
Samsung Biologics
Samsung Biologics' strike enters 5th day - Yonhap News Agency
eLife
Are kinocilia motile?
eLife
Human adherent cortical organoids in a multi-well format
Endpoints News
Vertex drops mRNA cystic fibrosis program over 'tolerability' issues
Bio-Rad
Bio-Rad Navigates Academic Headwinds and Geopolitical Shifts in Q1 2026 Financial Results - Lab Manager
FierceBiotech
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
الأرشيف
هذا المقال غير متوفر في الأرشيف.